Home Tags United States

Tag: United States

Occupational Exposure to Particulate Matter and Volatile Organic Compounds in Two Indoor Cannabis Production Facilities

7/22/20--In this current study, occupational exposures to particulate matter (PM) and volatile organic compounds (VOCs) in various task zones of two indoor cannabis facilities in Washington State were quantified. The observations from this study can help inform the employer of the task zones where exposure to respiratory hazards are the highest, and where it may be beneficial to deploy control measures to reduce worker exposures. Read

In shadow of pandemic, U.S. drug overdose deaths resurge to record

7/15/20--Drug deaths in America, which fell for the first time in 25 years in 2018, rose to record numbers in 2019 and are continuing to climb, a resurgence that is being complicated and perhaps worsened by the coronavirus pandemic. Read

FDA issues draft guidance on cannabis research

7/22/20--The Food and Drug Administration yesterday issued draft guidance for cannabis researchers. It is “limited to the development of human drugs and does not cover other FDA-regulated products.” Read

A Systematic Review with Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease

7/20/20--A number of studies have investigated the effectiveness  for treatment of inflammatory bowel diseases (IBD). This study aimed to systematically analyze the effect of cannabis or cannabinoids in the treatment of inflammatory bowel diseases (IBD) patients. Results indicate that Cannabi(noid)s do not induce clinical remission or affect inflammation in IBD patients. However, cannabi(noid)s significantly improve patient-reported symptoms and QoL. Read

Traditional PTSD therapy doesn’t trigger drug relapse

7/20/20--Researchers have now demonstrated that behavior therapy that exposes people to memories of their trauma doesn't cause relapses of opioid or other drug use, and that PTSD severity and emotional problems have decreased after the first therapy session. Read

Content Analysis of Instagram Posts From 2019 With Cartoon-Based Marketing of e-Cigarette–Associated Products

7/20/20--Studies have indicated that cartoons are an effective strategy in increasing product recognition and susceptibility to use e-cigarettes. Recently, the US Food and Drug Administration announced it is prioritizing enforcement against e-cigarette companies that use marketing likely to promote youth use. This study aimed to determine if companies were using cartoon-based strategies to market and promote e-cigarette–associated products in 2019 on Instagram. Read

PANDA: The Birth of a Pan-American Drug-User Alliance

7/20/20--Representatives from some leading drug user-led, community-based groups have recently been meeting online to work collectively against the cycle of drug-war oppression and death. Pan-American Network of Drug-user Activists—PANDA—was created to abolish prohibition. Read

Midwestern Hemp Database Project seeks grower participation

7/16/20--The goal of this project is to provide regional (Illinois, Indiana, Wisconsin and Michigan) insight into agronomic performance and cannabinoid development of modern hemp varieties. This project will rely heavily on dedicated grower cooperation to provide useful information to experienced and new growers interested hemp production. Read

Evaluation of the potential use of cannabidiol in the treatment of cocaine use disorder: A systematic review

9/1/20--The evidence found in this study indicates that CBD is a promising adjunct therapy for the treatment of cocaine dependence due to its effect on: cocaine reward effects, cocaine consumption, behavioral responses, anxiety, neuronal proliferation, hepatic protection and safety. Moreover, clinical trials are strongly required to determine whether the findings in animal models occur in humans diagnosed for cocaine or crack cocaine use disorder. Read

Controversial e-cigarette company Puff Bar says it’s suspending U.S. sales

7/13/20--Puff Bar, a California-based marketer of disposable e-cigarettes, announced the sales suspension Monday on its website. In a phone call with FairWarning, the company’s Chief Financial Officer Patrick Beltran confirmed that U.S. sales were being halted until further notice, but said that international sales would continue for the time being. Beltran would not give a reason for the move. Read

Effect of inhaled cannabis for pain in adults with sickle cell disease a randomized clinical trial

7/17/20-- This randomized clinical trial found that, compared with vaporized placebo, vaporized cannabis did not statistically significantly reduce pain and associated symptoms, except interference in mood, in patients with SCD with chronic pain. Read

States allow misleading claims that cannabis can treat opioid addiction

7/15/20--Though there's no evidence that cannabis can treat opioid use disorder, medical boards in four states -- Pennsylvania, New York, New Jersey and New Mexico -- include the disorder among conditions that qualify a person to access marijuana for medical purposes. Shover and her colleagues found that in the Northeastern states where that is the case, more dispensaries make advertising claims that cannabis can treat opioid addiction than they do in adjacent states. Read

Association of state policies allowing medical cannabis for opioid use disorder with dispensary marketing for this indication

7/14/20--According to this study, state-level policies designating opioid use disorder (OUD) as a qualifying condition for medical cannabis were associated with more dispensaries claiming cannabis can treat OUD. Future studies linking dispensary advertisements to health outcomes in people with OUD (eg, use of MOUDs, overdose mortality) are warranted, as are investigations into advertising that addresses other conditions with major morbidity and mortality consequences. Read

Reducing vaping among youth and young adults

7/1/20--This guide supports health care providers, systems, and communities seeking to prevent vaping. It describes relevant research findings, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers useful resources. Read

Commend Biden for resisting Big Marijuana | opinion

7/14/20--The Biden-Sanders joint presidential task force recently issued recommendations for a unity platform to move forward on a number of hot button issues. Among them: marijuana legalization, which the task force notably chose not to endorse, siding instead with decriminalization and research. Several commentators—from publications like National Review to The Atlantic and The Nation—chided Biden for not endorsing pot. But, according to a Newsweek op-ed by president and CEO of Smart Approaches to Marijuana Kevin Sabet, the former vice president should be commended for siding with science, not politics. Read

You know what else has sold well during the pandemic? Weed edibles

7/13/20--Pandemic anxiety and mounting concerns about vaping have contributed to the increase of cannabis product sales. Since March, the cannabis industry has seen an influx of new customers, and as fear of inhaled products has risen — spurred partly by studies of “vaping illness” and exacerbated by respiratory risks associated with the coronavirus — many consumers have opted to enjoy cannabis in edible form. Read

Cannabis use among US adults with anxiety from 2008 to 2017: The role of state-level cannabis legalization

9/1/20--According to study results, cannabis use is increasing among American adults overall, yet is disproportionately common among Americans with anxiety especially among those residing in states where cannabis has been legalized. Read

SEC files charges in $25 million cannabis-related offering fraud

7/29/20--The Securities and Exchange Commission today announced charges against six individuals and their companies for defrauding investors in connection with unregistered securities offerings that raised over $25 million. Read

Novel Insights on Cannabis and Psychosis

7/28/20--There is evidence in both patients with psychotic disorders and the general population that cannabis use is associated with adverse effects of psychopathology and cognition. Read

LaMalfa leads bipartisan group of lawmakers in introducing bill to eradicate illegal marijuana grows on public lands

7/9/20--Congressman Doug LaMalfa issued the following statement after he and Rep. Jared Huffman, Rep. Doug Lamborn, Rep. Salud Carbajal, Rep. Hal Rogers, and Rep. TJ Cox introduced the Protecting Lands Against Narcotics Trafficking (PLANT) Act. This legislation provides resources to help local, state, and federal law enforcement eradicate illegal marijuana grows on public lands and establishes a fund to restore land that has been damaged by illegal cultivation activities. Read

FTC order stops the marketer of “Thrive” supplement from making baseless claims it can treat, prevent, or reduce the risks from COVID-19

7/10/20--The California-based marketer of a supplement called Thrive, which consists mainly of Vitamin C and herbal extracts, is barred from continuing to make baseless claims that it can treat, prevent, or reduce the risk of COVID-19, under an administrative settlement with the Federal Trade Commission announced today. Read

Increasing popularity of 7/10 exemplifies rise in cannabis concentrates

7/10/20--July 10, also known as 710 or Oil Day, is the cannabis industry’s second annual “holiday.” Although not as popular or as well celebrated as 4/20, July 10 has picked up steam in recent years due to the rising popularity of concentrated cannabis products. Read

CBD may be legal, but challenges still persist in obtaining CBD product trademark registration

7/7/20--Last week, the Trademark Trial and Appeal Board (TTAB) ruled that a Colorado Cannabidiol (CBD) company could not register a trademark for hemp oil extracts because it violated the Food, Drug & Cosmetics Act (FDCA). Trademark registrations associated with cannabis have repeatedly been refused because they cannot be “lawfully used in commerce." Read

Drug overdoses: The hidden epidemic in the pandemic

7/5/20--Suspected cases of drug overdoses soared between March and May, according to data from medical teams,hospitals and the police. According to a Washington Post report, the isolation and economic upheaval caused by the pandemic are fueling this hidden epidemic. Heather Long who co-wrote that story joins Hari Sreenivasan to discuss. Read

Medical marijuana: A clinical handbook provides readers the most up-to-date insights on the science of cannabis and its medicinal use

7/7/20--A new textbook, Medical Marijuana: A Clinical Handbook provides an objective look at the history and science of the plant and strips away the cultural and political baggage that often clouds any meaningful examination of cannabis's therapeutic value. The authors, Drs. Samoon Ahmad and Kevin P. Hill, wrote the book to provide clinicians with the most accurate information available on cannabis and empower them to give their patients the best advice on treatment. Read

Is marijuana really harmless?

7/8/20--According to an article published in Rare Lake National News, it is reported that many people who regularly use marijuana may believe that the drug is relatively safe. However, marijuana is a mind-altering substance that can create negative long-term consequences, both bodily and mentally. Furthermore, regular marijuana use can create long-term memory problems, issues with brain development in younger users, and detrimental mental health problems. Read

Wirecard under criminal scrutiny by U.S. authorities as part of probe into alleged bank-fraud conspiracy

7/8/20--The Justice Department is examining whether scandal-plagued German payment company Wirecard AG played a critical role in an alleged $100 million bank-fraud conspiracy connected to an online marijuana marketplace, according to people familiar with the investigation. Two businessmen have already been charged in the alleged fraud, accused of conspiring with third-party payment processors and others to trick U.S. banks into approving credit-card payments for marijuana products. Read

Marijuana use while pregnant boosts risk of children’s sleep problems

7/2/20--Sleep Health: The Journal of The National Sleep Foundation is the latest paper to link prenatal cannabis use to developmental problems in children and the first to suggest it may impact sleep cycles long-term. It comes at a time when—while the number of pregnant women drinking alcohol and smoking cigarettes has declined in the United States—It has risen to 7% of all pregnant women as legalization spreads and more dispensaries recommend it for morning sickness. Read

As signature deadlines approach, here’s where marijuana and drug policy reform campaigns stand

7/2/20--Several drug policy reform campaigns are in the final stretch as deadlines to submit signatures for proposed ballot initiatives loom this week and next. The proposed ballot measures would accomplish everything from legalizing cannabis to decriminalizing psychedelics such as psilocybin and ayahuasca. This article provides a status update on where they stand. Read

Feds hire hazmat firm for marijuana eradication training

7/6/20--The U.S. Forest Service will spend nearly $50,000 to hire a hazardous materials consulting firm to train employees how to safely remove marijuana grown on public lands under a newly awarded government contract. The agency says the training is needed to protect employees, some of whom reportedly have been taken to emergency rooms after being exposed to hazardous chemicals while clearing marijuana plants in years past. Read

NCIS warns Navy after LSD investigations surge 70%

7/2/20--The Naval Criminal Investigative Service issued a warning about the drug activity, which they say is largely taking place on the dark web, a difficult-to-regulate portion of the internet accessible only via specific configurations. In a release, NCIS officials said users of illicit substances purchased on the dark web risk their own safety, and asked those with information about the LSD activity to come forward and report. Read

Innovative Industrial Properties announces exercise of option to purchase additional shares of common stock

7/2/20--Innovative Industrial Properties, Inc. announced today the full exercise of the underwriters’ option to purchase an additional 402,504 shares of common stock in connection with the Company’s previously announced follow-on offering that priced on June 29, 2020. In total, the Company sold 3,085,867 shares of common stock in the offering, raising gross offering proceeds of approximately $258.7 million. Read

Curaleaf announces private placement of subordinate voting shares

7/2/20--Curaleaf Holdings, Inc., a leading multi-state cannabis operator in the United States, announces today a private placement of up to C$27,500,000 of subordinate voting shares of the Company (the "Subordinate Voting Shares") at a price of C$7.70 per Subordinate Voting Share (the "Offering"). The Offering is being conducted in connection with the anticipated closing of the proposed and pending acquisition of GR Companies, Inc. d/b/a ‎Grassroots. Read

A scoping review on clinical trials of pain with cannabis administration in adults

7/1/20--Indications of cannabis use are numerous although the indication to relief pain remains a major research interest and clinical application. Studies investigating the effect of herbal cannabis and cannabis-based medicine on neuropathic, non-neuropathic pain, acute pain and experimentally induced pain were reviewed. Cannabis-based medications were found most effective as an adjuvant therapy in refractory multiple sclerosis, and weak evidence was found to support the treatment of cancer pain especially in advanced stages. Read

The word of God in the Age of legal larijuana

6/28/20--As more believers begin to tolerate legalization, current and former religious leaders find themselves in the middle of a debate over health, race and law enforcement. Read

Notes from the Field: E-cigarette, or Vaping, Product Use — Associated lung cases during the COVID-19 response

6/26/20--In April 2020, during the early COVID-19 pandemic, eight patients hospitalized with e-cigarette, or vaping, product use–associated lung injury (EVALI) were reported to the California Department of Public Health (CDPH). According to the report, it is unclear whether EVALI cases have continued to occur and were underreported or missed or whether these cases might represent the background incidence of EVALI as previously identified by CDC review of syndromic data. Read

‘Cash is king’ for expansion opportunities and COVID-19 cushion: Q&A with Charlotte’s Web CEO Deanie Elsner

7/2/20--Deanie Elsner joined Charlotte’s Web as CEO last year. She told Hemp Industry Daily that moving into the CBD market at the helm of Charlotte’s Web has been “fun, challenging and quite and adrenaline rush” and the Colorado-based company has been a good fit for her background of specializing in corporate turnarounds. In this interview with Hemp Industry Daily, Elsner provides insight on the company’s recent acquisition and global expansion plans and offers her take on the impact of COVID-19, the U.S. Food and Drug Administration’s regulatory delay and what is needed for the industry to move forward. Read

Parents’ marijuana use may increase children’s risk of marijuana use and favorable views of marijuana

6/30/20--When parents use drugs such as marijuana, their children may also be affected. Numerous studies have shown that current parental marijuana use increases the children’s risk of substance use and other psychiatric problems. A recent NIDA-sponsored study demonstrates that the parents’ history of marijuana use throughout their lifetime may also affect their children’s outcomes and that some lifetime use patterns are more harmful than others. Read

Congressman, leaders in the legal marijuana space to talk about reform, business at this special live event

6/27/20--Advance 360 in collaboration with NJ Cannabis Insider will host a national webinar “Cannabis Reform 2020: America’s Growing Pains & Possibilities” on July 13, featuring heavyweights in the cannabis space to discuss national and regional cannabis policy. Read

Tobacco users turn to CBD in search of an indicative substitute

6/29/20--According to data provided by the Brightfield Group and published by Hemp Industry Daily, a survey of more than 5,000 CBD users in the U.S. reveals that 24% have used it to help quit smoking and quitters are often replacing cigarettes with either smokable hemp or vaping. And, 41% of quitters have entirely replaced tobacco with hemp CBD. Read

Bipartisan senators file marijuana and CBD research amendment to defense spending bill

6/29/20--Sens. Dianne Feinstein (D-CA), Chuck Grassley (R-IA) and Brian Schatz (D-HI) are trying to attach marijuana and CBD research language to a large-scale defense spending bill that’s on the Senate floor this week. The senators are seeking to include the proposal—titled the Cannabidiol and Marijuana Research Expansion Act—in the annual renewal of the National Defense Authorization Act. Read

Marty Baron made The Post great again. Now, the news is changing.

6/28/20--According to an article by Ben Smith published in The New York Times, the revival of The Washington Post by the executive editor Mr. Baron and its owner, the Amazon founder, Jeff Bezos, is perhaps the greatest news business success story of the past decade. But that journalistic revival has in some ways masked a messier story, one of many contradictions. Read

The importance of cannabis and its use in bakery products

6/30/20--In this study, the relation of cannabis with food and health was examined, and the physical, chemical, textural and sensory effects on the products were examined with the use of this product in the production of different bakery products such as bread, gluten-free bread, and pasta. Read

Motor Carrier Safety Advisory Committee (MCSAC); public meeting

6/25/20--Federal Motor Carrier Safety Administration (FMCSA) announces a meeting of the MCSAC, which will take place via videoconference. The meeting will be held Monday, July 13, and Tuesday, July 14, 2020, from 9:15 a.m. to 4:30 p.m., Eastern Time. Read

HBO teams up with marijuana companies to sell THC gummies promoting new TV series

6/29/20--HBO is partnering up with major marijuana businesses to market a line of promotional cannabis edible gummies meant to bring attention to an animated series premiering next week, the entertainment giant announced on Monday.Each blend was developed to produces effects the network says reflect the personalities of the four main characters from “Close Enough,” which will be streaming on HBO Max. Read

Research identify more than 100 toxic chemicals in cannabis smoke

6/25/20--University of Alberta engineering researchers have characterized the potentially hazardous particles in cannabis smoke and have raised awareness about their potential health effects. Read

E-cigarettes

6/23/20--This webpage gives an overview of tobacco companies’ interests in e-cigarettes, also known as electronic cigarettes or ENDS (Electronic Nicotine Delivery Systems), which have been acquired, developed and sold by tobacco companies since 2012. It also links to further pages giving more detailed information about each company’s products, market share and business strategy, including methods used to promote their products around the world. Read

DFC National Evaluation Annual Report

7/1/20--The data in this year’s report demonstrates the commitment of the DFC coalitions to produce meaningful results in communities across the country. DFC coalitions reported a decrease in youth use of alcohol, tobacco, marijuana, and the misuse of prescription drugs. This means more middle school and high school youth are choosing not to use these substances in DFC funded communities. Read

2020 ONDCP DFC Evaluation Report

7/1/20--The Drug-Free Communities (DFC) Support Program 2020 National Evaluation End-of-Year Report was prepared by the DFC National Evaluation Team at ICF and provides an update on findings from the DFC National Evaluation. This report first provides an overview of the history and background of the DFC program. Next, evaluation findings are presented in four sections: Building Capacity, Strategy Implementation, Core Measures Findings, and Promising Practices. Read

Barriers in accessing medical cannabis for children with drug-resistant epilepsy in Canada

6/19/20--Results of this qualitative story indicate that parents pursue medical cannabis as a treatment for their children's drug-resistant epilepsy because of a perceived unmet need. However, parents encounter barriers in accessing medical cannabis in Canada, and strategies are needed to ensure that children using medical cannabis receive proper care from healthcare professionals with training in epilepsy care, antiepileptic drugs, and medical cannabis. Read

Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis

6/20/20--Studies of individual pure compounds found in cannabis have demonstrated, as highlighted in this review article, that many of the compounds present in cannabis could be part of a therapeutic solution for specific problems found during cancer treatment. However, additional clinical studies are needed to clarify whether some of these compounds (alone or in combination with other anticancer agents) could be useful in anticancer therapies. Read

Acreage Holdings reports first quarter 2020 results

6/25/20--Acreage Holdings, Inc. today reported financial results for the first quarter of 2020. In short, first quarter reported revenue was $24.2 million, an 88% increase compared to the same period in 2019, and a 15% increase compared to the fourth quarter of 2019. Net loss attributable to Acreage was $172 million, while adjusted net income attributable to Acreage was $14.7 million. Read

Canopy Growth & Acreage Holding agree to modify plan of arrangement as Canopy Growth’s U.S. expansion continues

6/25/20--Canopy Growth and Acreage Holdings agree to amend plan of arrangement to provide potential additional upside for all shareholders. The amended arrangement provides for up-front cash payment to Acreage shareholders and certain convertible security holders in the aggregate amount of $37,500,000. Read

Politicians must recognize Americans’ changing perceptions of marijuana

6/25/20--Marijuana’s increasingly prominent role in American society, and therefore in shaping public policy, raises important questions concerning what Americans really think about marijuana — and in line with these shifting perceptions, how to move forward as a nation with legalization and commercialization. Read

New Report: CBD companies using “research” as marketing tool could mislead consumers and risk public

6/24/20--Consumers for Safe CBD founding member, National Consumers League (NCL) today released a white paper that explores the great lengths that some unscrupulous CBD manufacturers are taking to sell unregulated, untested products in the marketplace at the risk of public health. This includes trying to legitimize medical claims by leveraging the reputation of academic medical centers—despite the lack of evidence to support those claims. Read

Why more states could legalize cannabis in 2021

6/25/20--Actions by states to reduce criminal penalties for marijuana use and possession are fueling momentum for the broader movement to legalize cannabis and have it serve as an economic engine for cash-strapped coffers, industry members and policy experts say. Karen O'Keefe, director of state policies for the Marijuana Policy Project, expects a record number of states to legalize marijuana in 2021, in part due to the financial pressures, along with the racial injustice imperative to reduce unnecessary police-civilian interactions. Read

Bank fraud allegations test marijuana business

7/1/20--Prosecutors allege scheme to disguise $100 million in cannabis product sales in a case that could have implications for industry. Read

Military invests $27M to develop new class of psychedelics-inspired drugs

6/24/20--Funded by $26.9 million from the U.S. Department of Defense’s Defense Advanced Research Projects Agency (DARPA), a new project announced this month “aims to create new medications to effectively and rapidly treat depression, anxiety, and substance abuse without major side effects,” according to a University of North Carolina (UNC) School of Medicine press release. Read

Little-noticed hemp memo clarifies military’s ban on service members using CBD

6/22/20--Since hemp was federally legalized, various military branches have issued guidance, broadly prohibiting active duty members from using products derived from the crop despite the legal status change. But a little-noticed memo is helping to explain the trend. The memo states that regular use of lawful hemp products could result in a positive urinalysis test for THC. Additionally, the FDA does not certify THC concentrations in CBD products that are widely available in the marketplace, it says. Read

Reducing Impaired Driving Fatalities: Data Need to Drive Testing, Enforcement, and Policy

6/22/20--The 2 studies evaluating the association of recreational cannabis laws with motor vehicle crash deaths by Santaella-Tenorio et al and Kamer et al in this issue of JAMA Internal Medicine contribute to an emerging body of research necessary to inform policy on cannabis and impaired driving. Both studies use natural experiments in policy implementation to provide a high-level perspective of how legalization of recreational cannabis use may affect motor vehicle crash deaths in the population. Read